Announcement PDF ASX Announcement 2 September 2024 Change of Joint Company Secretary Role Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) advises, that in accordance with ASX Listing Rule 3.16.1, that Mr. Peter Webse has resigned from his position as Joint Company Secretary, effective 31 August 2024. Mr. Webse joined Microba as Joint Company Secretary on 1 January 2022 to assist the Company with its ASX Initial Public Offering (IPO) on 5 April 2022. Over the past two and half years, he has assisted the Microba group diligently. The Board of Directors extends its sincere gratitude to Mr. Webse for his contributions and wishes him every success in his future endeavours. The Company confirms that Mr. James Heath will continue as Company Secretary and will assume full responsibility for communications between the Company and the ASX, in accordance with ASX Listing Rule 12.6. - Ends This announcement has been authorised for release by the Chair and Chief Executive Officer. For further information, please contact: Dr Luke Reid Chief Executive Officer luke.reid@microba.com https://ir.microba.com/welcome About Microba Life Sciences Limited Microba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions. For more information visit www.microba.com . JOIN MICROBA’S INTERACTIVE INVESTOR HUB ir.microba.com/welcome interact with Microba’s announcements and updates by asking questions and comments which our team can respond to where possible. Microba Life Sciences Ltd ABN 82 617 096 652 Level 10, 324 Queen Street, Brisbane QLD 4000 Australia, 1300 974 621